Magnesium is an essential intracellular cation involved in hundreds of enzymatic reactions, including ATP-dependent processes, neuromuscular conduction, glucose regulation, and cardiovascular rhythm stabilization. Magnesium deficiency (hypomagnesemia) is clinically important because it can mimic or worsen neurologic, muscular, and cardiac conditions, and it frequently coexists with deficiencies in potassium and calcium due to shared renal handling mechanisms.
Physiology and why deficiency matters: Most magnesium is stored in bone and within cells; only a small fraction circulates in serum. Serum magnesium can therefore underestimate total body magnesium deficit. Magnesium stabilizes excitable membranes by modulating calcium and potassium flux and by acting as a physiologic antagonist to N-methyl-D-aspartate (NMDA) signaling. It also influences insulin sensitivity and parathyroid hormone (PTH) secretion; low magnesium can impair PTH release and action, contributing to functional hypocalcemia.
Common causes: Dietary insufficiency is one contributor, particularly with low intake of magnesium-rich foods (nuts, legumes, whole grains, leafy greens). However, clinical hypomagnesemia is often driven by impaired absorption or increased losses. Gastrointestinal losses occur with chronic diarrhea, malabsorption syndromes (e.g., celiac disease, inflammatory bowel disease), and after bariatric surgery. Renal wasting is another major category: certain medications increase urinary magnesium excretion, including loop and thiazide diuretics, aminoglycosides, cisplatin, calcineurin inhibitors (tacrolimus, cyclosporine), and proton pump inhibitors with prolonged use in susceptible individuals. Uncontrolled diabetes and osmotic diuresis can also promote urinary magnesium loss. Alcohol use disorder increases risk through poor intake, GI losses, and tubular dysfunction.
Clinical manifestations: Symptoms are often nonspecific early and become clearer with more pronounced deficiency. Neuromuscular signs include tremor, muscle cramps, fasciculations, weakness, and in severe cases tetany or seizures. Neuropsychiatric features may include irritability, agitation, and insomnia; magnesium is linked to stress physiology and neurotransmitter balance, although causality in mood disorders is complex and multifactorial. Cardiovascular effects can include palpitations, prolonged QT interval, and arrhythmias, especially when coexisting hypokalemia is present. Metabolic consequences include worsening insulin resistance and glucose control.
Associated electrolyte abnormalities: Hypomagnesemia commonly co-travels with hypokalemia. Magnesium is required for normal potassium reabsorption; without adequate magnesium, potassium replacement may fail until magnesium is corrected. Hypocalcemia may also occur because low magnesium can lead to impaired PTH secretion.
Diagnosis and evaluation: Diagnosis begins with serum magnesium, but interpretation requires clinical context. Because serum values may be relatively preserved until deficiency is advanced, clinicians should assess risk factors, symptoms, medications, renal function, and concurrent electrolyte results. Standard laboratory evaluation often includes serum potassium and calcium, renal function tests, and review of contributing drugs. If hypomagnesemia is confirmed, evaluation should identify the pathway: dietary, gastrointestinal, or renal. Fractional excretion of magnesium and urine studies may be used in selected cases, particularly when renal wasting is suspected.
Treatment principles: Management depends on severity and symptoms. For mild, asymptomatic deficiency, oral magnesium is typically preferred, with selection tailored to tolerance and comorbidities. Magnesium salts differ in elemental magnesium content and gastrointestinal side effects; some forms (e.g., magnesium citrate) can be more laxative. For moderate to severe symptoms (e.g., seizures, significant arrhythmias) or markedly low magnesium, intravenous magnesium sulfate is used under monitored conditions.
Address reversible drivers: Correct the underlying cause—optimize diet, treat diarrhea or malabsorption, adjust diuretic or interacting medications when feasible, and manage diabetes and alcohol use disorder. When hypokalemia or hypocalcemia is present, replacement should prioritize magnesium because restoring magnesium facilitates subsequent correction of potassium and calcium.
Dietary sources and prevention: Prevention emphasizes magnesium-rich foods such as legumes, nuts and seeds, whole grains, cocoa, and leafy greens. For patients with persistent risk factors (chronic GI disease, long-term diuretic therapy, bariatric surgery, or medication-related renal wasting), clinicians may recommend periodic monitoring and individualized supplementation.
Safety considerations: Magnesium supplementation is generally safe in individuals with normal kidney function. In chronic kidney disease, magnesium can accumulate and cause hypotension, bradyarrhythmias, and neurologic depression. Therefore, dosing should be individualized and renal function should be considered.
Prognosis: When identified and treated, magnesium deficiency often improves neurologic irritability, muscle symptoms, and electrolyte abnormalities. However, persistent deficiency indicates an ongoing cause (medication effects, malabsorption, or renal wasting) that requires targeted evaluation.
Source: lizzytush84 (via https://x.com/lizzytush84/status/2079623046717907133)
Betty ✝️: @Ravious101 Its probably magnesium deficiency. Along with other vitamins and minerals we dont get from the sh*t food we eat. #breaking
— @lizzytush84 May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
